1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX

Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Read More
85.23 3.87 (4.76%)
152.91% Gain from 52W Low
1.1M
XNAS Volume

XNAS 14 Jan, 2026 4:03 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
30.5 / 100
Momentum Score
Technically Neutral
56.5 / 100
Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM
Analyst Price Target
96
1Yr Price target upside is 13%
12 analysts

16

S

15

W

3

O

1

T

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..